-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Medical Network, February 24 News On February 22, Neptunus Biopharmaceuticals issued an announcement stating that sildenafil citrate tablets (50mg, 100mg) of the holding subsidiary Shenzhen Neptunus Medicine have been approved for listing
.
Sildenafil is a mainstream anti-ED drug.
According to Meinenet data, in 2019, the sales of sildenafil in physical pharmacies in cities in China exceeded 2.
3 billion yuan, a year-on-year increase of 7.
42%
.
Sildenafil Citrate Tablets is used to treat erectile dysfunction (ED) and is a selective inhibitor of phosphodiesterase type 5 (PDE-5) developed by Pfizer
.
PDE-5 inhibitor drugs are the main anti-ED products.
Sildenafil, tadalafil, and vardenafil are the three main PDE-5 inhibitors in the global market
.
The sales of sildenafil at physical pharmacies in cities in China (unit: 10,000 yuan) Source: Mynet.
com Competitive pattern of sildenafil at physical pharmacies in cities in China In the physical pharmacy market, sildenafil is the leading product of urinary systemic drugs
.
According to data from Menet.
com, in 2019, the sales of sildenafil at the physical pharmacy terminal in Chinese cities exceeded 2.
3 billion yuan, a year-on-year increase of 7.
42%
.
Among them, Baiyunshan Pharmaceutical General Factory ranked first with 48.
77% market share, followed by the original research manufacturer Pfizer with 46.
52%
.
The brand pattern of Sildenafil in China's urban physical pharmacies in 2019.
Source: Mynet.
com.
Chinese urban physical pharmacies.
The competitive structure of sildenafil.
Currently, the domestically marketed sildenafil dosage forms include ordinary tablets and orally disintegrating tablets, and sildena citrate.
Only the original manufacturer of non-orally disintegrating tablets is approved by Pfizer, and the manufacturers of Sildenafil Citrate tablets include Pfizer, Baiyunshan, Yabang Epson, Diao Pharmaceutical, Jinheng Pharmaceutical, Changshan Pharmaceutical, Qilu Pharmaceutical , Langsheng Pharmaceutical and Neptunus Pharmaceuticals and other 9 companies
.
The listing application of sildenafil citrate tablets is under review and approval.
Source: One-click search on Mynet.
com Although sildenafil has been included in the third batch of centralized procurement, there are still many domestic pharmaceutical companies applying for imitation
.
Yangtze River Pharmaceutical, Dongyang Sunshine Pharmaceutical, Guangshengtang Pharmaceutical, China Resources Secco Pharmaceutical.
.
.
7 pharmaceutical companies submitted applications for the listing of sildenafil citrate tablets according to the new registration classification and are under review and approval
.
Source: Mi Nei.
com database Note: Mi Nei.
com China's urban entity pharmacy terminal competition pattern database is an enlarged version of urban entity pharmacies that covers 293 prefectures and above cities across the country (excluding county and rural entity pharmacies), and continuously monitors all categories Database
.
The above sales are calculated based on the average retail price of the product at the terminal
.
.
Sildenafil is a mainstream anti-ED drug.
According to Meinenet data, in 2019, the sales of sildenafil in physical pharmacies in cities in China exceeded 2.
3 billion yuan, a year-on-year increase of 7.
42%
.
Sildenafil Citrate Tablets is used to treat erectile dysfunction (ED) and is a selective inhibitor of phosphodiesterase type 5 (PDE-5) developed by Pfizer
.
PDE-5 inhibitor drugs are the main anti-ED products.
Sildenafil, tadalafil, and vardenafil are the three main PDE-5 inhibitors in the global market
.
The sales of sildenafil at physical pharmacies in cities in China (unit: 10,000 yuan) Source: Mynet.
com Competitive pattern of sildenafil at physical pharmacies in cities in China In the physical pharmacy market, sildenafil is the leading product of urinary systemic drugs
.
According to data from Menet.
com, in 2019, the sales of sildenafil at the physical pharmacy terminal in Chinese cities exceeded 2.
3 billion yuan, a year-on-year increase of 7.
42%
.
Among them, Baiyunshan Pharmaceutical General Factory ranked first with 48.
77% market share, followed by the original research manufacturer Pfizer with 46.
52%
.
The brand pattern of Sildenafil in China's urban physical pharmacies in 2019.
Source: Mynet.
com.
Chinese urban physical pharmacies.
The competitive structure of sildenafil.
Currently, the domestically marketed sildenafil dosage forms include ordinary tablets and orally disintegrating tablets, and sildena citrate.
Only the original manufacturer of non-orally disintegrating tablets is approved by Pfizer, and the manufacturers of Sildenafil Citrate tablets include Pfizer, Baiyunshan, Yabang Epson, Diao Pharmaceutical, Jinheng Pharmaceutical, Changshan Pharmaceutical, Qilu Pharmaceutical , Langsheng Pharmaceutical and Neptunus Pharmaceuticals and other 9 companies
.
The listing application of sildenafil citrate tablets is under review and approval.
Source: One-click search on Mynet.
com Although sildenafil has been included in the third batch of centralized procurement, there are still many domestic pharmaceutical companies applying for imitation
.
Yangtze River Pharmaceutical, Dongyang Sunshine Pharmaceutical, Guangshengtang Pharmaceutical, China Resources Secco Pharmaceutical.
.
.
7 pharmaceutical companies submitted applications for the listing of sildenafil citrate tablets according to the new registration classification and are under review and approval
.
Source: Mi Nei.
com database Note: Mi Nei.
com China's urban entity pharmacy terminal competition pattern database is an enlarged version of urban entity pharmacies that covers 293 prefectures and above cities across the country (excluding county and rural entity pharmacies), and continuously monitors all categories Database
.
The above sales are calculated based on the average retail price of the product at the terminal
.